Overview

Ultrasound-Guided Stellate Ganglion Block With Botulinum

Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
0
Participant gender:
All
Summary
the local stellate ganglion block with bupivacaine and corticosteroid treatment for acute peripheral facial nerve palsy in patients can induce hyperglycemia, and an alternative local therapy may be necessary and some time may ve ineffective. Our purpose in this study is to evaluate therapeutic effects of stellate ganglion block (SGB) Botulinum Toxin on referactory facial nerve palsy
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Criteria
Inclusion Criteria:

- Diagnosed by clinical and neurological assessment as one-sided idiopathic facial palsy

- Age 18 to 60 •-ASA i-II

Exclusion Criteria:

- Exclusion Criteria:

- diabetic

- coagulation dysfunction

- mental or cognitive dysfunclion

- allergy to injected medication